PQQ Activ (Pyrroloquinoline quinone)

Pyrroloquinoline quinone (PQQ) is a quinone compound that functions as a redox cofactor in bacterial enzymes and exhibits antioxidant properties based on its chemical structure. Currently, no human clinical trials support health benefits, with available research limited to mechanistic studies on its role as a prosthetic group in bacterial dehydrogenases.

Origin & History

PQQ (pyrroloquinoline quinone) is a redox cofactor and antioxidant originally discovered in 1964 in bacteria such as Klebsiella and Acetobacter. It is biosynthesized from the amino acids glutamate and tyrosine through a multi-enzyme pathway involving genes pqqA to pqqF, with the final oxidation step catalyzed by the enzyme PqqC.

Historical & Cultural Context

PQQ has no documented traditional or historical medicinal uses. It was discovered in 1964 as a bacterial redox cofactor, with no links to traditional medicine systems or cultural practices.

Health Benefits

• No clinical health benefits can be reported - the research dossier contains no human clinical trials or studies
• The compound functions as a redox prosthetic group in bacterial dehydrogenases (mechanistic data only)
• Acts as an antioxidant based on its chemical structure (theoretical, no clinical evidence)
• May facilitate electron transfer processes (demonstrated only in bacterial systems)
• No evidence-based health claims can be made from the available research

How It Works

PQQ functions as a redox prosthetic group in bacterial dehydrogenases, facilitating electron transfer reactions in oxidative processes. The compound's quinone structure allows it to cycle between oxidized and reduced states, theoretically providing antioxidant activity through electron donation. However, the specific molecular pathways and enzyme interactions in human physiology remain undefined due to lack of clinical research.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses for PQQ or PQQ Activ were found in the research dossier. The available research focuses solely on the compound's bacterial biosynthesis pathways and biochemical mechanisms in non-human systems.

Clinical Summary

No human clinical trials or studies are available in the research dossier for PQQ, preventing any evidence-based health benefit claims. The existing research is limited to mechanistic data demonstrating its role in bacterial enzyme systems. Without human studies, dosing protocols, efficacy outcomes, and safety parameters cannot be established. The lack of clinical evidence represents a significant limitation in understanding PQQ's potential therapeutic applications.

Nutritional Profile

PQQ (Pyrroloquinoline quinone) is a redox-active ortho-quinone compound (molecular formula: C14H6N2O8, molecular weight: 330.21 g/mol), not a conventional macronutrient or micronutrient. It is classified as a quinone cofactor and is not synthesized endogenously in humans. Typical supplemental doses range from 10–20 mg per serving. PQQ is found in trace dietary amounts in foods: fermented soybeans (natto) ~61 ng/g, green tea ~30 ng/mL, human breast milk ~140–180 ng/mL, and most fruits/vegetables at 1–7 ng/g dry weight. It contains no caloric value, no fiber, no protein, and no conventional vitamin or mineral content. As a bioactive compound, its primary characterized property is its redox cycling capacity — it can undergo reversible two-electron reduction to its reduced form (PQQH2), enabling electron transfer. It is water-soluble, which theoretically supports intestinal absorption, though human bioavailability data from clinical studies is absent. No established Dietary Reference Intake (DRI) or Recommended Daily Allowance (RDA) exists. The compound is structurally distinct from B-vitamins despite occasional informal comparisons; it does not meet the clinical criteria for vitamin classification in humans.

Preparation & Dosage

No clinically studied dosage ranges are available in the research. No information on forms (extract, powder, standardized) or dosing protocols has been established through clinical research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of clinical research

Safety & Interactions

Safety data for PQQ supplementation is insufficient due to the absence of human clinical trials in the available research. Potential side effects, appropriate dosing ranges, and contraindications cannot be determined without clinical study data. Drug interactions and effects during pregnancy or breastfeeding are unknown. Individuals considering PQQ supplementation should consult healthcare providers given the limited safety profile information.